|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||3.6300 - 3.6600|
|52 Week Range||0.5500 - 4.4900|
|Beta (5Y Monthly)||-0.41|
|PE Ratio (TTM)||N/A|
|Earnings Date||Apr 13, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||3.00|
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Biostage The Trade: Biostage, Inc. (OTC: BSTG) 10% owner Dst Capital Llc acquired a total of 500000 shares at an average p
Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing novel organ regeneration technology based its patented Cellframe™ and Cellspan™ technology, today announced the appointment of Jerry He as an independent director to its Board of Directors, adding strength in the areas of business innovation, strategy and finance.
Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing next-generation esophageal implants based its novel Cellframe™ and Cellspan™ technology, today announced its financial results for the three and six months ended June 30, 2021.